← Portfolio Scout

Portfolio company

BioLamina

Sweden · £14.4m raised

Raised

£14.4m

Latest stage

Growth

Rounds recorded

1

Backed by

1 investor

Sectors

Deep TechDigital Health

About

This company produces recombinant human laminin proteins used as cell culture substrates by researchers and regenerative medicine companies to develop stem cell therapies.

Source

Funding history · 1

Similar companies